Shareholders Equity (Annual)

Shareholders Equity: The sum of preferred and common equity items.

Renalytix plc - Sponsored ADR (RNLXD) had Shareholders Equity of $-7.00M for the most recently reported fiscal year, ending 2025-06-30.

Quarterly Annual

Figures for fiscal year ending 2025-06-30

Income Statement Financials
Revenue	$3.00M
Net Income	$-20.40M
Cost of Goods Sold	$1.80M
Gross Profit	$1.20M
Operating Expenses	$20.20M
Operating Income	$-17.20M
Non-Operating Income/Expense	$-4.60M
Pre-Tax Income	$-21.80M
Normalized Pre-Tax Income	$-21.20M
Income after Taxes	$-20.40M
Income from Continuous Operations	$-20.40M
Consolidated Net Income/Loss	$-20.40M
Normalized Income after Taxes	$-19.76M
EBIT	$-17.20M
EBITDA	$-17.20M
Weighted-Average Shares Outstanding (Basic)	145.72M
Weighted-Average Shares Outstanding (Diluted)	145.72M
Earnings per Share (EPS) (Basic)	$-0.14
Earnings per Share (EPS) (Diluted)	$-0.14
Balance Sheet Financials
Current Assets	$5.80M
Property, Plant, and Equipment	$0.20M
Long-Term Assets	$0.30M
Total Assets	$6.10M
Current Liabilities	$4.80M
Long-Term Debt	$8.30M
Long-Term Liabilities	$8.30M
Total Liabilities	$13.10M
Common Equity	$-7.00M
Tangible Shareholders Equity	$-7.00M
Shareholders Equity	$-7.00M
Common Shares Outstanding	165.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-17.90M
Cash Flow from Investing Activities	$0.00M
Cash Flow from Financial Activities	$16.00M
Beginning Cash	$4.70M
End Cash	$3.60M
Increase/Decrease in Cash	$-1.10M
Stock-Based Compensation	$3.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.21
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	6.38
Debt to Equity Ratio	-1.19
Gross Margin	40.00%
Operating Margin	-573.33%
EBIT Margin	-573.33%
EBITDA Margin	-573.33%
Pre-Tax Profit Margin	-726.67%
Profit Margin	-680.00%
Free Cash Flow	$-17.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	9.00
Receiveable Turnover	5.00
Days Sales in Receivables	73.00
Return on Equity	291.43%
Return on Tangible Equity	291.43%
Return on Assets	-334.43%
Return on Investments	-1569.23%
Book Value Per Share	$-0.04
Free Cash Flow per Share	$-0.12
Operating Cash Flow per Share	$-0.12

Data from Zacks Investment Research, Inc.